{"transactions":[{"id":2282318,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":127595,"kind":"person","name":"Hawkinson Russ","position":1,"cik":"0001831807","reported_name":"Hawkinson Russ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President of Finance"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-04T21:00:02.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":56670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest on May 2, 2023."}],"balance_after":56670,"derivative":{"exercise_price":3.15,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":56670},"source":{"system":"sec-edgar","filing":"0001209191-22-027144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122027144/doc4.xml","form_type":"4"}},{"id":2282317,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":127595,"kind":"person","name":"Hawkinson Russ","position":1,"cik":"0001831807","reported_name":"Hawkinson Russ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President of Finance"}}],"security":"Common Stock","published_at":"2022-05-04T21:00:02.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":28335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":37251,"source":{"system":"sec-edgar","filing":"0001209191-22-027144","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122027144/doc4.xml","form_type":"4"}},{"id":2374791,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":127595,"kind":"person","name":"Hawkinson Russ","position":1,"cik":"0001831807","reported_name":"Hawkinson Russ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President of Finance"}}],"security":"Common Stock","published_at":"2022-02-25T00:55:23.000Z","date":"2020-12-08","kind":"purchase","acquired":true,"shares":200,"price":21,"value":4200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased in the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"On December 8, 2020, the reporting person filed a Form 4 in which he inadvertently reported a purchase of 238 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person purchased 200 shares of the issuer's common stock."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001209191-22-012878","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122012878/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-08"}},{"id":2416722,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":127595,"kind":"person","name":"Hawkinson Russ","position":1,"cik":"0001831807","reported_name":"Hawkinson Russ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President of Finance"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T22:22:43.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":28500,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001209191-22-006444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122006444/doc4.xml","form_type":"4"}},{"id":2416721,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":127595,"kind":"person","name":"Hawkinson Russ","position":1,"cik":"0001831807","reported_name":"Hawkinson Russ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President of Finance"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T22:22:43.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in equal monthly installments over the 48 months following February 1, 2022."}],"balance_after":45000,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-22-006444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122006444/doc4.xml","form_type":"4"}},{"id":2416720,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":127595,"kind":"person","name":"Hawkinson Russ","position":1,"cik":"0001831807","reported_name":"Hawkinson Russ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President of Finance"}}],"security":"Common Stock","published_at":"2022-02-02T22:22:43.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,216 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2021."}],"balance_after":8954,"source":{"system":"sec-edgar","filing":"0001209191-22-006444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122006444/doc4.xml","form_type":"4"}},{"id":2953491,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":127595,"kind":"person","name":"Hawkinson Russ","position":1,"cik":"0001831807","reported_name":"Hawkinson Russ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President of Finance"}}],"security":"Common Stock","published_at":"2020-12-09T01:52:54.000Z","date":"2020-12-08","kind":"purchase","acquired":true,"shares":238,"price":21,"value":4998.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased in the Issuer's initial public offering."}],"balance_after":238,"source":{"system":"sec-edgar","filing":"0001209191-20-062401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919120062401/doc4.xml","form_type":"4"}},{"id":2955214,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":127595,"kind":"person","name":"Hawkinson Russ","position":1,"cik":"0001831807","reported_name":"Hawkinson Russ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President of Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-08T00:49:00.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":102038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over the 48 months following December 3, 2020."}],"balance_after":102038,"derivative":{"exercise_price":21,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":102038},"source":{"system":"sec-edgar","filing":"0001209191-20-062045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919120062045/doc4.xml","form_type":"4"}}]}